摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-amino-3-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-ribofuranosyl]-3,5,6,7-tetrahydro-2H-pyrrolo[2,3-d]pyrimidin-2-one | 258502-42-0

中文名称
——
中文别名
——
英文名称
7-amino-3-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-ribofuranosyl]-3,5,6,7-tetrahydro-2H-pyrrolo[2,3-d]pyrimidin-2-one
英文别名
1-amino-5-(3,5-di-O-p-tuluoyl-β-D-2-deoxyribofuranosyl)-2,3-dihydro-5H-pyrrolidino[2,3-d]pyrimidin-6-one;[(2R,3S,5R)-5-(7-amino-2-oxo-5,6-dihydropyrrolo[2,3-d]pyrimidin-3-yl)-3-(4-methylbenzoyl)oxyoxolan-2-yl]methyl 4-methylbenzoate
7-amino-3-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-ribofuranosyl]-3,5,6,7-tetrahydro-2H-pyrrolo[2,3-d]pyrimidin-2-one化学式
CAS
258502-42-0
化学式
C27H28N4O6
mdl
——
分子量
504.543
InChiKey
WCXMVYSNJHVWBP-YTFSRNRJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    37
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    124
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙酸酐7-amino-3-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-ribofuranosyl]-3,5,6,7-tetrahydro-2H-pyrrolo[2,3-d]pyrimidin-2-one吡啶 为溶剂, 以80%的产率得到1-(acetylamino)-5-(3,5-di-O-p-toluoyl-β-D-2-deoxyribofuranosyl)-2,3-dihydro-5H-pyrrolidino[2,3-d]pyrimidin-6-one
    参考文献:
    名称:
    The Syntheses of Pyrimido-pyridazinone and Pyrrolidino-pyrimidinone 2′-Deoxynucleoside Derivatives
    摘要:
    Nucleosides that have ambivalent tautomeric properties have value in a variety of nucleic-acid hybridisation applications and as mutagenic agents. We describe here synthetic studies directed to stable derivatives based on N-4-aminocytosine. Treatment of the 5-(chloroethyl)-4-(triazol-1-yl)pyrimidine-nucleoside derivative 1 with benzylhydrazine leads to the formation of the 6,6-bicyclic pyrimido-pyridazin-7-one 6, in addition to the 5,6-bicyclic derivative 7. The 6,6-bicyclic benzyl derivative 6 was converted to its 5'-triphosphate for studies with DNA polymerases. Reaction of the triazole 1 with hydrazine, followed by acetylation,led to the desired acetylated 6,6-bicyclic derivative 12. However, the latter compound undergoes acyl migration followed by ring contraction to the 5,6-bicyclic compound 13 on treatment with base.
    DOI:
    10.1002/1522-2675(20000809)83:8<1693::aid-hlca1693>3.0.co;2-e
  • 作为产物:
    描述:
    6-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-ribofuranosyl]-2,3,4,6-tetrahdyropyrimido[4,5-c][1,2]pyridazin-7(1H)-one三乙胺 作用下, 以 乙腈 为溶剂, 以73%的产率得到7-amino-3-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-ribofuranosyl]-3,5,6,7-tetrahydro-2H-pyrrolo[2,3-d]pyrimidin-2-one
    参考文献:
    名称:
    The Synthesis of BicyclicN4-Amino-2′-deoxycytidine Derivatives
    摘要:
    Nucleosides which have ambivalent tautomeric properties have value in a variety of nucleic acid hybridization applications, and as mutagenic agents. We describe here synthetic studies directed to stable derivatives of this kind of nucleoside based on N-4-aminocytosine. Treatment of the 4-(1H-1,2,4-triazol-1-yl)-5-(chloroethyl)pyrimidinone nucleoside derivative 5 with hydrazine leads to formation of the 6,6-bicyclic pyrimido-pyridazin-7-one 3, and with methylhydrazine to the corresponding fixed tautomeric I-methyl derivative 7 (Scheme 1). If these cyclization reactions are carried out in the presence of a base, the 6-ring bicyclic derivatives undergo rearrangement to their corresponding 5-ring pyrrolo-pyrimidin-2-one analogues 8 (Scheme 2). In the reaction of the triazolyl derivative 5 with 1-[(benzyloxy)carbonyl]-2-methylhydrazine, spontaneous cyclization gives the 5-ring derivative 13 related to 8 rather than the open-chain product 12 (Scheme 4). Reaction of an acetylated analogue of triazolyl derivative 5 with 1,1-dimethylhydrazine gives rise to some of the open-chain product 9, but it too cyclizes to a product that we have assigned the structure of the 6,6-ring quaternary ammonium salt 11 (Scheme 3).
    DOI:
    10.1002/(sici)1522-2675(19991110)82:11<2028::aid-hlca2028>3.0.co;2-e
点击查看最新优质反应信息